UpRight Science, Inc.

UpRight Science develops FDA-cleared balance assessment and fall-risk detection technology for clinical and research use. The company's core offering is a medical-grade, AI-driven platform that quantifies balance and gait dynamics to identify fall risks, neurological decline, and medication side effects. Their technology integrates machine learning algorithms trained on biomechanical datasets to provide clinicians and researchers with actionable insights for patient stratification and early intervention. The platform is validated in clinical trials and marketed as addressing balance as "the sixth vital sign"—positioning fall prevention as a critical health metric alongside traditional vital signs. UpRight Science targets healthcare providers, physical therapy clinics, geriatric care facilities, and research institutions. The technology combines motion analysis with predictive analytics to detect deviations linked to neurodegenerative diseases and other conditions affecting balance and gait. The company emphasizes evidence-based development leveraging decades of balance science research. Their go-to-market approach includes direct sales to clinical and research institutions via demonstrations and proof-of-concept studies.